Oculis (OCS) News Today

Shares of Oculis Holding AG (NASDAQ:OCS - Get Free Report) have been given a consensus recommendation of "Buy" by the six brokerages that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year price ob

Oculis (NASDAQ:OCS) Shares Up 2.3%

Oculis Holding AG (NASDAQ:OCS - Get Free Report) has been given an average recommendation of "Buy" by the six research firms that are currently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average 12-month price objective among broke

Oculis Holding AG (NASDAQ:OCS - Get Free Report) was the recipient of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 26,600 shares, a decrease of 42.2% from the May 15th total of 46,000 shares. Approximately 0.1% of the company's stock are short sold. Based on an average trading volume of 37,100 shares, the short-interest ratio is currently 0.7 days.

Chardan Capital restated a "buy" rating and set a $30.00 price objective on shares of Oculis in a research note on Tuesday.

HC Wainwright increased their price objective on shares of Oculis from $28.00 to $30.00 and gave the company a "buy" rating in a report on Tuesday.

Bank of America lowered their price objective on shares of Oculis from $21.00 to $20.00 and set a "buy" rating for the company in a research report on Tuesday.

Pivotal bioVenture Partners Investment Advisor LLC lessened its stake in Oculis Holding AG (NASDAQ:OCS - Free Report) by 14.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,888,788 shares of the company's

Oculis Holding AG (NASDAQ:OCS - Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 46,000 shares, an increase of 16.8% from the April 30th total of 39,400 shares. Based on an average trading volume of 39,100 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.2% of the company's shares are sold short.

Oculis Holding AG (NASDAQ:OCS - Free Report) - Investment analysts at HC Wainwright reduced their Q2 2024 EPS estimates for shares of Oculis in a research report issued to clients and investors on Monday, May 13th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings

Oculis Holding AG (NASDAQ:OCS - Free Report) - Equities research analysts at HC Wainwright issued their FY2025 earnings per share estimates for shares of Oculis in a report issued on Monday, May 13th. HC Wainwright analyst Y. Chen expects that the company will earn ($1.62) per share for the year.

HC Wainwright reaffirmed a "buy" rating and set a $28.00 price target on shares of Oculis in a research note on Monday.

Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume

Oculis (NASDAQ:OCS) Shares Up 8.3%

Oculis Holding AG (NASDAQ:OCS - Get Free Report) was the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 25,600 shares, a decline of 21.0% from the March 31st total of 32,400 shares. Based on an average daily volume of 51,100 shares, the short-interest ratio is currently 0.5 days. Currently, 0.1% of the company's stock are sold short.

Oculis Holding AG (NASDAQ:OCS - Free Report) - Equities research analysts at HC Wainwright raised their Q2 2024 earnings estimates for Oculis in a research report issued on Wednesday, April 24th. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings of ($0.37) per share

abrdn plc purchased a new stake in Oculis Holding AG (NASDAQ:OCS - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 1,452,741 shares of the company's stock, valued at approximately $15,980,000. abrdn plc owned approximately 3.9

HC Wainwright lowered their price target on Oculis from $29.00 to $28.00 and set a "buy" rating on the stock in a report on Wednesday.

Oculis Holding AG (NASDAQ:OCS - Get Free Report) was the target of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 32,400 shares, a decrease of 31.4% from the March 15th total of 47,200 shares. Approximately 0.2% of the company's stock are short sold. Based on an average trading volume of 37,700 shares, the short-interest ratio is currently 0.9 days.

Oculis Holding AG (NASDAQ:OCS - Get Free Report) has received an average rating of "Buy" from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts th